Literature DB >> 7222145

Inhibition of bovine adrenocortical cytochrome P-450scc by 3,3'-dimethoxybenzidine.

J F Duval, L E Vickery.   

Abstract

The effect of 3,3'=dimethoxybenzidine (o-dianisidine) on the conversion of cholesterol to pregnenolone was investigated in a reconstituted side chain cleavage system using enzymes purified from bovine adrenal cortex; d-p-aminoglutethimide was also assayed under similar conditions for comparison. 3,3'-Dimethoxybenzidine was found to be a potent inhibitor of pregnenolone formation, causing 50% inhibition at a concentration of 1.5 microM when using 70 microM cholesterol - this dose is approximately one fourth that required of 3-methoxybenzidine and one twentieth that required of benzidine for equal inhibition. In the same system, d-p-aminoglutethimide exhibited an I50 value of about 55 microM. No effects of 3,3'-dimethoxybenzidine on adrenodoxin reductase or adrenodoxin activities could be detected, and inhibition of side chain cleavage could be relieved by dilution suggesting that the inhibitor acts by reversibly binding to cytochrome P-450scc.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7222145     DOI: 10.1016/0039-128x(81)90011-8

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  3 in total

1.  Direct inhibition of cyclooxygenase pathway in platelets by tixocortol 21-pivalate: comparison with related structures, steroidal and non steroidal anti-inflammatory drugs.

Authors:  V Lelievre; B Martin; J Bure; J L Junien
Journal:  Agents Actions       Date:  1988-06

2.  Effects of aminoglutethiumide and its metabolite, N-acetylaminoglutethimide, on bovine adrenocortical and human placental cytochromes P-450scc.

Authors:  J J Sheets; L E Vickery
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

3.  Proximity of the substrate binding site and the heme-iron catalytic site in cytochrome P-450scc.

Authors:  J J Sheets; L E Vickery
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.